Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Expression of Toll-Like Receptor 4 in Glomerular Endothelial Cells under Diabetic Conditions.

Takata S, Sawa Y, Uchiyama T, Ishikawa H.

Acta Histochem Cytochem. 2013 Feb 28;46(1):35-42. doi: 10.1267/ahc.13002. Epub 2013 Feb 15.

2.

Altered dynamics in the renal lymphatic circulation of type 1 and type 2 diabetic mice.

Uchiyama T, Takata S, Ishikawa H, Sawa Y.

Acta Histochem Cytochem. 2013 Apr 30;46(2):97-104. doi: 10.1267/ahc.13006. Epub 2013 Apr 12.

3.

Expression of toll-like receptor 2 in glomerular endothelial cells and promotion of diabetic nephropathy by Porphyromonas gingivalis lipopolysaccharide.

Sawa Y, Takata S, Hatakeyama Y, Ishikawa H, Tsuruga E.

PLoS One. 2014 May 16;9(5):e97165. doi: 10.1371/journal.pone.0097165. eCollection 2014.

4.

Anti-diabetic effects of globin digest and its active ingredient Leu-Ser-Glu-Leu in ICR mice, streptozotocin-induced diabetic mice and KK-Ay mice.

Nakaoka F, Sasakawa Y, Yamamoto K, Nakao M, Nakamura M, Tong C, Fukuhama C, Kagawa K.

Life Sci. 2010 Mar 13;86(11-12):424-34. doi: 10.1016/j.lfs.2010.01.014. Epub 2010 Jan 25.

PMID:
20109472
5.

Gene expression profile in streptozotocin-induced diabetic mice kidneys undergoing glomerulosclerosis.

Wada J, Zhang H, Tsuchiyama Y, Hiragushi K, Hida K, Shikata K, Kanwar YS, Makino H.

Kidney Int. 2001 Apr;59(4):1363-73.

6.

Glomerular changes in the KK-Ay/Ta mouse: a possible model for human type 2 diabetic nephropathy.

Ito T, Tanimoto M, Yamada K, Kaneko S, Matsumoto M, Obayashi K, Hagiwara S, Murakoshi M, Aoki T, Wakabayashi M, Gohda T, Funabiki K, Maeda K, Horikoshi S, Tomino Y.

Nephrology (Carlton). 2006 Feb;11(1):29-35.

PMID:
16509929
7.

The role of adrenomedullin and receptors in glomerular hyperfiltration in streptozotocin-induced diabetic rats.

Hiragushi K, Wada J, Eguchi J, Matsuoka T, Yasuhara A, Hashimoto I, Yamashita T, Hida K, Nakamura Y, Shikata K, Minamino N, Kangawa K, Makino H.

Kidney Int. 2004 Feb;65(2):540-50.

8.

The promotion of nephropathy by Porphyromonas gingivalis lipopolysaccharide via toll-like receptors.

Kajiwara K, Takata S, To TT, Takara K, Hatakeyama Y, Tamaoki S, Darveau RP, Ishikawa H, Sawa Y.

Diabetol Metab Syndr. 2017 Sep 22;9:73. doi: 10.1186/s13098-017-0271-8. eCollection 2017.

9.

Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice.

Liao J, Kobayashi M, Kanamuru Y, Nakamura S, Makita Y, Funabiki K, Horikoshi S, Tomino Y.

J Nephrol. 2003 Nov-Dec;16(6):841-9.

PMID:
14736011
10.

Comparison of renal morphology in the Streptozotocin and the SHR/N-cp models of diabetes.

Gross ML, Ritz E, Schoof A, Adamczak M, Koch A, Tulp O, Parkman A, El-Shakmak A, Szabo A, Amann K.

Lab Invest. 2004 Apr;84(4):452-64.

11.

Altered mouse cholinephosphotransferase gene expression in kidneys of type 2 diabetic KK/TA mouse.

Gohda T, Tanimoto M, Shiina K, Ito T, Kobayashi M, Hagiwara S, Kaneko S, Makita Y, Funabiki K, Horikoshi S, Tomino Y.

Metabolism. 2004 Jul;53(7):842-6.

PMID:
15254874
12.

Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice.

Fan Q, Liao J, Kobayashi M, Yamashita M, Gu L, Gohda T, Suzuki Y, Wang LN, Horikoshi S, Tomino Y.

Nephrol Dial Transplant. 2004 Dec;19(12):3012-20.

PMID:
15574998
13.

p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.

Wolf G, Schanze A, Stahl RA, Shankland SJ, Amann K.

Kidney Int. 2005 Oct;68(4):1583-9.

14.

Ay allele promotes azoxymethane-induced colorectal carcinogenesis by macrophage migration in hyperlipidemic/diabetic KK mice.

Ito K, Ishigamori R, Mutoh M, Ohta T, Imai T, Takahashi M.

Cancer Sci. 2013 Jul;104(7):835-43. doi: 10.1111/cas.12162. Epub 2013 May 25.

15.

Gene expression profile in diabetic KK/Ta mice.

Fan Q, Shike T, Shigihara T, Tanimoto M, Gohda T, Makita Y, Wang LN, Horikoshi S, Tomino Y.

Kidney Int. 2003 Dec;64(6):1978-85.

16.

Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats.

Sassy-Prigent C, Heudes D, Mandet C, Bélair MF, Michel O, Perdereau B, Bariéty J, Bruneval P.

Diabetes. 2000 Mar;49(3):466-75.

PMID:
10868970
17.

Effect of pioglitazone on the early stage of type 2 diabetic nephropathy in KK/Ta mice.

Tanimoto M, Fan Q, Gohda T, Shike T, Makita Y, Tomino Y.

Metabolism. 2004 Nov;53(11):1473-9.

PMID:
15536604
18.

Macrophage-mediated glucolipotoxicity via myeloid-related protein 8/toll-like receptor 4 signaling in diabetic nephropathy.

Kuwabara T, Mori K, Mukoyama M, Kasahara M, Yokoi H, Nakao K.

Clin Exp Nephrol. 2014 Aug;18(4):584-92. doi: 10.1007/s10157-013-0922-5. Epub 2013 Dec 20. Review.

19.
20.

Roles of connective tissue growth factor and prostanoids in early streptozotocin-induced diabetic rat kidney: the effect of aspirin treatment.

Makino H, Mukoyama M, Sugawara A, Mori K, Suganami T, Yahata K, Fujinaga Y, Yokoi H, Tanaka I, Nakao K.

Clin Exp Nephrol. 2003 Mar;7(1):33-40.

PMID:
14586741

Supplemental Content

Support Center